Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 23, 2023

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Lymphoblastic LeukemiaCancer SurvivorsAplastic AnemiaMyelodysplastic SyndromesMyeloid Leukemia
Interventions
DIETARY_SUPPLEMENT

Nicotinamide Riboside

"Investigators will use (Good Manufacturing Process) GMP-grade 300 mg capsules of the dietary supplement nicotinamide riboside (ChromaDex, Irvine CA).~NR is distributed by ChromaDex, Inc., Irvine, CA. NR is available as 300 mg capsules.~The dietary supplement will be re-labeled by the Hospital of the University of Pennsylvania (HUP) Investigational Drug Service according to FDA regulations, including subject and physician name and NR or Placebo 300 mg capsules."

DIETARY_SUPPLEMENT

Placebo

The matched placebo will contain the same excipients without the active supplement and is generally recognized as safe. The placebo will be covered in an identical capsule (NR will be covered in the same capsule)

OTHER

Exercise Intervention

The exercise program consists of at-home training sessions and will include aerobic and strengthening components designed to progress persons gradually to 150-300 minutes of the equivalent of moderate aerobic activity, and twice weekly strengthening over 16 weeks. For aerobic training, the eventual intensity and duration goal (adapted for each person as necessary) will be for persons to train at 70-80% of peak 2MSPT heart rate 20-45 minutes 3-5 days/week. For resistance exercises the goal will be a load/weight that results in fatigue after 3 sets of 10-12 repetitions on 8-10 exercises 2 days/week.

Trial Locations (3)

19104

RECRUITING

Children's Hospital of Philadelphia, Philadelphia

38105

RECRUITING

St. Jude Children's Research Hospital, Memphis

91010

RECRUITING

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

City of Hope Medical Center

OTHER

collaborator

St. Jude Children's Research Hospital

OTHER

collaborator

National Cancer Institute (NCI)

NIH

collaborator

University of Pennsylvania

OTHER

lead

Children's Hospital of Philadelphia

OTHER